NuPharm Laboratories Limited - in Administration

A closure plan for NuPharm Laboratories Limited (NuPharm) was announced in October 2016. Following that plan, NuPharm ceased manufacturing in October 2016 and ceased trading during January 2017.

Steven Phillip Ross and Allan David Kelly of RSM Restructuring Advisory LLP were appointed Joint Administrators of NuPharm on 26 April 2017. The affairs, business and property of the company over which they are appointed are managed by them as agents and without personal liability.

For all enquiries in relation to NuPharm other than product quality or adverse drug reaction (ADR) reporting, please contact the administrators directly:

Kelly Allison of RSM Restructuring Advisory LLP
Tel: 0191 255 7000
Kelly.Allison@rsmuk.com

For any queries around product quality or ADR reporting, please contact:

Tel: 0800 043 9372
Fax: 0800 043 9378
Email: medinfo@quantumpharma.co.uk